JPS61210036A - Sulfur-compounded external drug for skin - Google Patents
Sulfur-compounded external drug for skinInfo
- Publication number
- JPS61210036A JPS61210036A JP5194685A JP5194685A JPS61210036A JP S61210036 A JPS61210036 A JP S61210036A JP 5194685 A JP5194685 A JP 5194685A JP 5194685 A JP5194685 A JP 5194685A JP S61210036 A JPS61210036 A JP S61210036A
- Authority
- JP
- Japan
- Prior art keywords
- sulfur
- drug
- skin
- external
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title abstract description 11
- 229940079593 drug Drugs 0.000 title abstract description 11
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims abstract description 51
- 239000011593 sulfur Substances 0.000 claims abstract description 51
- 229910052717 sulfur Inorganic materials 0.000 claims abstract description 51
- 239000000843 powder Substances 0.000 claims abstract description 32
- 229920000642 polymer Polymers 0.000 claims abstract description 20
- 238000002360 preparation method Methods 0.000 claims description 27
- 230000000699 topical effect Effects 0.000 claims 1
- -1 polyethylene Polymers 0.000 abstract description 10
- 239000004698 Polyethylene Substances 0.000 abstract description 8
- 229920000573 polyethylene Polymers 0.000 abstract description 8
- 238000004519 manufacturing process Methods 0.000 abstract description 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract description 4
- 238000000034 method Methods 0.000 abstract description 4
- 206010000496 acne Diseases 0.000 abstract description 3
- 238000003860 storage Methods 0.000 abstract description 3
- 239000002537 cosmetic Substances 0.000 abstract description 2
- 239000003599 detergent Substances 0.000 abstract description 2
- 230000015271 coagulation Effects 0.000 abstract 2
- 238000005345 coagulation Methods 0.000 abstract 2
- 238000004061 bleaching Methods 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 238000013329 compounding Methods 0.000 abstract 1
- 229920000915 polyvinyl chloride Polymers 0.000 abstract 1
- 239000004800 polyvinyl chloride Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 239000002585 base Substances 0.000 description 11
- 238000001816 cooling Methods 0.000 description 10
- 239000004677 Nylon Substances 0.000 description 6
- 239000006185 dispersion Substances 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 229920001778 nylon Polymers 0.000 description 6
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 239000004743 Polypropylene Substances 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 230000002776 aggregation Effects 0.000 description 3
- 229920001155 polypropylene Polymers 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 229940075507 glyceryl monostearate Drugs 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 229940099259 vaseline Drugs 0.000 description 2
- USMCNVFGYLZLGM-AWEZNQCLSA-N (2s)-5-amino-2-(dodecanoylamino)-5-oxopentanoic acid Chemical compound CCCCCCCCCCCC(=O)N[C@H](C(O)=O)CCC(N)=O USMCNVFGYLZLGM-AWEZNQCLSA-N 0.000 description 1
- NPNPZTNLOVBDOC-UHFFFAOYSA-N 1,1-difluoroethane Chemical compound CC(F)F NPNPZTNLOVBDOC-UHFFFAOYSA-N 0.000 description 1
- FDCJDKXCCYFOCV-UHFFFAOYSA-N 1-hexadecoxyhexadecane Chemical compound CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC FDCJDKXCCYFOCV-UHFFFAOYSA-N 0.000 description 1
- OEPOKWHJYJXUGD-UHFFFAOYSA-N 2-(3-phenylmethoxyphenyl)-1,3-thiazole-4-carbaldehyde Chemical compound O=CC1=CSC(C=2C=C(OCC=3C=CC=CC=3)C=CC=2)=N1 OEPOKWHJYJXUGD-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000003255 anti-acne Effects 0.000 description 1
- 229940038596 anti-acne preparations for topical use preparations containing sulfur Drugs 0.000 description 1
- 239000003518 caustics Substances 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920003053 polystyrene-divinylbenzene Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 235000011118 potassium hydroxide Nutrition 0.000 description 1
- 235000008476 powdered milk Nutrition 0.000 description 1
- 238000009895 reductive bleaching Methods 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/731—Cellulose; Quaternized cellulose derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0241—Containing particulates characterized by their shape and/or structure
- A61K8/0275—Containing agglomerated particulates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/23—Sulfur; Selenium; Tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/88—Polyamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/12—Face or body powders for grooming, adorning or absorbing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/60—Particulates further characterized by their structure or composition
- A61K2800/61—Surface treated
- A61K2800/62—Coated
- A61K2800/622—Coated by organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/60—Particulates further characterized by their structure or composition
- A61K2800/61—Surface treated
- A61K2800/62—Coated
- A61K2800/624—Coated by macromolecular compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Detergent Compositions (AREA)
Abstract
Description
【発明の詳細な説明】
[産業上の利用分野]
本発明は硫黄とともに皮膚外用剤基剤に不溶の粉末を配
合することにより、その配合製剤の安定性を向上させた
皮膚外用剤に関するものである。[Detailed Description of the Invention] [Field of Industrial Application] The present invention relates to a skin external preparation that improves the stability of the combined preparation by incorporating an insoluble powder into the skin external preparation base together with sulfur. be.
[従来の技術]
従来硫黄はに営びの予防、治療の目的で軟膏、クリーム
、洗顔料などに用いられたり、還元漂白を目的として多
くの皮膚外用剤に用いられている。[Prior Art] Sulfur has conventionally been used in ointments, creams, facial cleansers, etc. for the purpose of preventing and treating acne scarring, and has been used in many external skin preparations for the purpose of reductive bleaching.
しかしながら硫黄は皮膚外用剤中で、製造中あるいは保
存中に凝集し、均一分散ができないばかりか凝集物は沈
降を加速し、品質の劣化を増長するものであった。However, sulfur aggregates in skin preparations during manufacturing or storage, making it impossible to disperse uniformly, and the aggregates accelerate sedimentation, increasing deterioration of quality.
[発明が解決しようとしている問題点]本発明者らは係
る事情に鑑み鋭意研究の結果、皮膚外用剤の処方中に硫
黄とともに不溶性高分子粉末を配合すれば製造中はもち
ろん保存中ざえも硫黄の凝集が防止できることを見出し
本発明を完成するに至った。[Problems to be solved by the invention] In view of the above-mentioned circumstances, the present inventors have conducted intensive research and found that if insoluble polymer powder is combined with sulfur in the formulation of external skin preparations, sulfur will be released not only during manufacturing but also during storage. The present invention was completed based on the discovery that the aggregation of .
[問題点を解決するための手段および作用]すなわち、
本発明は硫黄とともに皮膚外用剤基剤に不溶の粉末を配
合することにより、その配合製剤の安定性を向上させた
ことを特徴とする皮膚外用剤である。[Means and actions for solving the problem] That is,
The present invention is a skin external preparation characterized by incorporating an insoluble powder into the skin external preparation base together with sulfur, thereby improving the stability of the combined preparation.
本発明で用いられる硫黄は通常皮膚外用剤用として供給
されているものでかまわなく、その配合量としては任意
であり、期待する効果の程度によって決定される。しか
し極端に硫黄の配合量が多い場合には皮膚外用剤基剤の
分量が少なくなり、皮膚外用剤基剤自身の性能を発揮出
来なくなる場合がある。好ましくは0.1〜10%であ
る。The sulfur used in the present invention may be one that is normally supplied for external use on the skin, and the amount of sulfur to be added is arbitrary and determined depending on the expected degree of effect. However, if the amount of sulfur blended is extremely large, the amount of the skin external preparation base will be reduced, and the skin external preparation base may not be able to exhibit its own performance. Preferably it is 0.1 to 10%.
また本発明において硫黄とともに皮膚外用剤に配合きれ
る不溶性高分子粉末としては水性皮膚外層剤基剤に°配
合きれるものとしてはポリエチレン、ポリプロピレン、
ポリスチレン、ポリスチレンジビニルベンゼン共重合体
などの炭化水素系の高分子、塩化ビニル、塩化ビニリデ
ン、弗化エチレンなどのハロゲン化炭化水素系の高分子
、ナイロンなどのポリアミド系高分子、アクリロニトリ
ル、メチルメタアクリレートなどのアクリル系高分子や
、フェノール系高分子、ポリエステル系高分子、などの
汎用合成高分子材料の粉末、あるいは結晶性セルロース
パウダーのような天然物由来の高分子粉末などが利用で
きる。In addition, in the present invention, insoluble polymer powders that can be incorporated into external skin preparations together with sulfur include polyethylene, polypropylene,
Hydrocarbon polymers such as polystyrene and polystyrene divinylbenzene copolymers, halogenated hydrocarbon polymers such as vinyl chloride, vinylidene chloride, and ethylene fluoride, polyamide polymers such as nylon, acrylonitrile, and methyl methacrylate. Powders of general-purpose synthetic polymer materials such as acrylic polymers such as phenol polymers and polyester polymers, and polymer powders derived from natural products such as crystalline cellulose powder can be used.
いずれの場合も本発明の効果を期待して配合する粉末は
配合する皮膚外用剤基剤に不溶のものを用いないと本発
明の効果は発揮されない。In any case, the effects of the present invention will not be exhibited unless the powder blended with the expectation of the effects of the present invention is insoluble in the base of the external skin preparation.
また油性の皮膚外用剤基剤中に配合される粉末としては
前述の高分子粉末のうち皮膚外用剤基剤との溶解性を考
慮すればそのほとんどがもちいれる。ざらに油性基剤の
場合にはショ糖、乳糖、糖アルコールなどの糖粉束も用
いることができる。Also, as the powder to be incorporated into the oil-based skin external preparation base, most of the above-mentioned polymer powders can be used in consideration of their solubility with the skin external preparation base. In the case of coarsely oily bases, powdered sugars such as sucrose, lactose, and sugar alcohols can also be used.
以上に述べた高分子粉末を一種または二種以上を用いる
が、その高分子粉末を配合する量としては同時に皮膚外
用剤に配合きれる硫黄の量とを考え合わせて決定される
。本発明の効果を発揮する量としては硫黄量の1/2以
上がのぞましい。また硫黄の量より極端に多い高分子粉
末を配合した場合、本発明の効果が減少するものではな
いが、前述の硫黄の場合と同様に皮膚外用剤基剤の分量
が減少し皮膚外用剤白層の性能を阻害することとなる。One or more of the above-mentioned polymer powders are used, and the amount of the polymer powder to be blended is determined by taking into consideration the amount of sulfur that can be blended into the external skin preparation. The amount to exhibit the effects of the present invention is preferably 1/2 or more of the amount of sulfur. Furthermore, if a polymer powder that is extremely larger than the amount of sulfur is blended, the effect of the present invention will not be reduced, but as in the case of sulfur, the amount of the skin external preparation base will decrease and the skin external preparation will become whiter. This will impede the performance of the layer.
本発明にしたがって硫黄と不溶性高分子粉末を配合され
る皮膚外用剤基剤としては、洗浄料をはじめニキビ治療
薬、美白化粧料などのもので、ゲル状、クリーム状など
の通常の皮膚外用剤基剤が利用できる。また製造時に溶
解状態で製造する固形石鹸にも応用できる。The base for external skin preparations containing sulfur and insoluble polymer powder according to the present invention includes detergents, anti-acne drugs, whitening cosmetics, etc., and is commonly used in gel-like, cream-like, etc. Bases are available. It can also be applied to solid soaps that are manufactured in a dissolved state during manufacturing.
本発明による手法で硫黄とともに不溶性高分子粉末を皮
膚外用剤に配合した場合、硫黄の凝集がなく非常に品質
のよい皮膚外用剤が得られたが、それに比較して硫黄の
みを配合したものは、皮膚外用剤
中で硫黄が凝集、沈降し著しい品質の劣化をおこした。When an insoluble polymer powder was blended with sulfur into a skin external preparation using the method of the present invention, a skin external preparation with very good quality without sulfur aggregation was obtained. , sulfur coagulated and precipitated in the external skin preparation, causing a significant deterioration in quality.
[実施列]
つぎに本発明を実施例および比較例によりざら° に詳
細に説明するが本発明はこれにより限定されるものでは
ない。[Example Series] Next, the present invention will be explained in detail with reference to Examples and Comparative Examples, but the present invention is not limited thereto.
〈実施例1〉
ラウロイルグルタミン11 25 w t%ナ
トリウム
ヤシ油ジェタノールアマイド 5PEG1500
15グリセリン
25グリセリルモノステアレート 2精製水
全体を100とする量香料
適量粉末硫黄
1ポリエチレン粉末 3硫
黄およびポリエチレンを除く成分を70’Cで加熱溶解
したのち、硫黄およびポリエチレンを仕込む。分散機に
より硫黄とポリエチレン粉末を均一に分散せしめ、その
のち冷却処理をおこない硫黄を安定に配合した洗浄料を
得る。<Example 1> Lauroyl glutamine 11 25 wt% sodium coconut oil jetanolamide 5PEG1500
15 Glycerin
25 Glyceryl monostearate 2 Purified water Amount to make the total 100 Fragrance
Appropriate amount of powdered sulfur
1. Polyethylene powder 3. After heating and melting all components except sulfur and polyethylene at 70'C, sulfur and polyethylene are charged. Sulfur and polyethylene powder are uniformly dispersed using a dispersing machine, and then a cooling process is performed to obtain a cleaning agent that stably contains sulfur.
く比較例1〉
実施例1の処方よりポリエチレン粉末を除いたもので、
硫黄以外の成分を70’Cで加熱溶解したのち硫黄を仕
込み、実施例1と同じ条件で分散処理、冷却処理したも
の。Comparative Example 1> The formulation of Example 1 except that the polyethylene powder was removed,
Components other than sulfur were heated and dissolved at 70'C, then sulfur was added, followed by dispersion treatment and cooling treatment under the same conditions as in Example 1.
実施例1および比較例1の洗顔料を分散処理直後(製造
釜内)、および冷却処理の開始直後、途中3個所、終了
直前の各ポイント(冷却機出口)でサンプリングし、試
料中の硫黄含有量を測定した。The facial cleansers of Example 1 and Comparative Example 1 were sampled immediately after the dispersion treatment (inside the production kettle), immediately after the start of the cooling treatment, at three points during the cooling treatment, and at each point just before the end (at the outlet of the cooling machine) to determine the sulfur content in the samples. The amount was measured.
表−1
表−1よりもあきらかなように硫黄のみを配合した比較
例1においては分散処理直後は硫黄が均一に分散してい
るものの、冷却処理に至るまでの時間に凝集がおこり、
その凝集物が早い速度で沈降するため、皮膚外用剤とし
ては硫黄の量が一定しない品質の悪いものである。Table 1 As is clearer from Table 1, in Comparative Example 1 in which only sulfur was blended, sulfur was uniformly dispersed immediately after the dispersion treatment, but agglomeration occurred during the time leading up to the cooling treatment.
Since the aggregates settle out at a high rate, it is of poor quality as an external preparation for the skin because the amount of sulfur is not constant.
これ゛に比べ実施例1では本発明にしたがって硫黄とと
もに不溶性高分子粉末(本例ではポリエチレン粉末)を
配合しであるため、分散処理直後の製造釜内ではもちろ
ん時間がたって冷却処理に移りざらには冷却処理終了ま
で硫黄量の一定した非常に優れた皮膚外用剤が得られる
。In contrast, in Example 1, in accordance with the present invention, insoluble polymer powder (polyethylene powder in this example) was blended with sulfur, so that it could not only be carried out in the production kettle immediately after dispersion treatment but also not transferred to cooling treatment over time. An extremely excellent skin preparation with a constant sulfur content until the end of the cooling process can be obtained.
これは本発明に係る効果である。This is an effect related to the present invention.
〈実施例2〉
アシルグルタミン酸 83.4vtXモノナ
トリウム
(WJ品名アミソフトG5−11)
セタノール 5.0精製水
9.○酸化チタン
0.1香料 適
量粉末硫黄 2.0ナイロンパ
ウダー 0.5硫黄およびナイロンパウ
ダー以外の成分を7000で加熱溶解したのち50°C
まで冷却する。<Example 2> Acylglutamic acid 83.4vtX monosodium (WJ product name Amisoft G5-11) Setanol 5.0 Purified water
9. ○Titanium oxide
0.1 Fragrance Appropriate amount Powdered sulfur 2.0 Nylon powder 0.5 Heat and melt the ingredients other than sulfur and nylon powder at 7000°C, then 50°C
Cool until cool.
そののち硫黄およびナイロンパウダーを分散処理し、つ
いで室温まで冷却する。ざらにブレンダーにより練合し
て硫黄を安定に配合した固形石鹸を得る。Thereafter, sulfur and nylon powder are dispersed and then cooled to room temperature. Roughly knead with a blender to obtain a solid soap containing stably blended sulfur.
〈実施例3〉
A、精製水 全体を100とする量グリセ
リン 10wt%苛性カリ
0.283セタノール
4ステアリン酸
2.5ワセリン 8流動パラ
フイン 10グリセリルモノステアレ
ート 3イソプロピルミリステート 5
エチルパラベン 0.2香料
適量C0粉末硫黄
0.5セルロースパウダー
5Aの成分、Bの成分をそれぞれ70’Cにて加熱
溶解したのちAのなかへBを加え乳化する。モののちC
の硫黄およびセルロースパウダーを加え、分散処理した
のち冷却処理をおこない、硫黄を安定に配合した皮膚外
用剤を得る。<Example 3> A. Purified water Amount to make the whole 100 Glycerin 10wt% Caustic potassium
0.283 cetanol
4 stearic acid
2.5 Vaseline 8 Liquid paraffin 10 Glyceryl monostearate 3 Isopropyl myristate 5
Ethylparaben 0.2 fragrance
Appropriate amount of C0 powder sulfur
0.5 cellulose powder
Component 5A and component B are respectively heated and dissolved at 70'C, and then B is added to A and emulsified. Monochi C
Add sulfur and cellulose powder, perform a dispersion treatment, and then perform a cooling treatment to obtain a skin preparation with a stable blend of sulfur.
〈実施例4〉
A、精製水 全体を100とする量エチル
アルコール 5.○wtχプロピレングリ
コール 10.○カルボキシビニルポリマー
0.8B、粉末硫黄 5.○ポ
リプロピレンパウダー 5.OC0苛性カリ
0.2Aの成分を室温で溶解した
のちBの粉末硫黄およびポリプロピレンパウダーを添加
する。分散処理を施した後、Cのアルカリを加えて中和
し、硫黄を安定に配合したゲル状皮膚外用剤を得る。<Example 4> A. Purified water Ethyl alcohol in an amount with the total as 100 5. ○wtχ Propylene glycol 10. ○Carboxyvinyl polymer
0.8B, powdered sulfur 5. ○Polypropylene powder 5. OC0 caustic potash
After 0.2 components A are dissolved at room temperature, powdered sulfur and polypropylene powder B are added. After the dispersion treatment, an alkali (C) is added to neutralize the mixture to obtain a gel-like skin preparation stably containing sulfur.
〈実施例5〉
A、ワセリン 40wt%固形パ
ラフィン 2
ピースワツクス 2
POE (20)セチルエーテル 2ステアリ
ン酸 2
シリコンオイル 2
スクワラン 35
香料 適量
B、粉末硫黄 10粉末乳I!3
ナイロンパウダー 2 。<Example 5> A, Vaseline 40wt% solid paraffin 2 Piece wax 2 POE (20) Cetyl ether 2 Stearic acid 2 Silicone oil 2 Squalane 35 Fragrance Appropriate amount B, Powdered sulfur 10 Powdered milk I! 3. Nylon powder 2.
Aの成分を75°Cで溶解したのも55°Cまで冷却す
る。そののちBの硫黄、乳糖、ナイロンパウダーを添加
し分散処理する。ついで冷却処理を行い、硫黄を安定に
配合した軟膏状皮膚外用剤を得る。The component A dissolved at 75°C is also cooled to 55°C. After that, sulfur, lactose, and nylon powder (B) are added and dispersed. Then, a cooling treatment is performed to obtain an ointment-like external preparation for skin containing a stable combination of sulfur.
Claims (1)
する皮膚外用剤A topical skin preparation that is characterized by containing sulfur and insoluble polymer powder.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5194685A JPS61210036A (en) | 1985-03-15 | 1985-03-15 | Sulfur-compounded external drug for skin |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5194685A JPS61210036A (en) | 1985-03-15 | 1985-03-15 | Sulfur-compounded external drug for skin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS61210036A true JPS61210036A (en) | 1986-09-18 |
Family
ID=12901037
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP5194685A Pending JPS61210036A (en) | 1985-03-15 | 1985-03-15 | Sulfur-compounded external drug for skin |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS61210036A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0249714A (en) * | 1988-08-12 | 1990-02-20 | Shiseido Co Ltd | Cosmetic |
| JPH032124A (en) * | 1989-05-30 | 1991-01-08 | Terumo Corp | Liquid agent for external application |
| JPH11228346A (en) * | 1998-02-12 | 1999-08-24 | Kose Corp | Cosmetic |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS49126583A (en) * | 1973-04-09 | 1974-12-04 | ||
| JPS5083268A (en) * | 1973-11-29 | 1975-07-05 | ||
| JPS53145906A (en) * | 1977-05-25 | 1978-12-19 | Yamanouchi Pharmaceut Co Ltd | Stable aqueous dispersion of 10-propionyl gosamycin |
| JPS5446820A (en) * | 1977-08-18 | 1979-04-13 | Upjohn Co | Pharmaceutical liquid suspending agent composition |
-
1985
- 1985-03-15 JP JP5194685A patent/JPS61210036A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS49126583A (en) * | 1973-04-09 | 1974-12-04 | ||
| JPS5083268A (en) * | 1973-11-29 | 1975-07-05 | ||
| JPS53145906A (en) * | 1977-05-25 | 1978-12-19 | Yamanouchi Pharmaceut Co Ltd | Stable aqueous dispersion of 10-propionyl gosamycin |
| JPS5446820A (en) * | 1977-08-18 | 1979-04-13 | Upjohn Co | Pharmaceutical liquid suspending agent composition |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0249714A (en) * | 1988-08-12 | 1990-02-20 | Shiseido Co Ltd | Cosmetic |
| JPH032124A (en) * | 1989-05-30 | 1991-01-08 | Terumo Corp | Liquid agent for external application |
| JPH11228346A (en) * | 1998-02-12 | 1999-08-24 | Kose Corp | Cosmetic |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3658451B2 (en) | Benzoyl peroxide composition | |
| US5952395A (en) | Gelled ultrafine oil-in-water emulsion stabilized with a crosslinked poly(2-acrylamido-2-methylpropanesulfonic acid) polymer neutralized to at least 90% process of preparation and applications | |
| JPH08225465A (en) | Composition in the form of dispersion and process for its preparation | |
| JPH10212226A (en) | Topical composition containing at least one protein of plant origin and / or at least one protein of animal origin and at least one cross-linked poly (2-acrylamido-2-methylpropanesulfonic acid) | |
| CA2174031C (en) | Benzoyl peroxide compositions | |
| JP2000256188A (en) | Emulsifier composition | |
| CA1142854A (en) | Method and compositions for the treatment of seborrhea | |
| JP2000290135A (en) | Agent for promoting restoration of skin barrier function | |
| JPS61210036A (en) | Sulfur-compounded external drug for skin | |
| JPH06157237A (en) | Humectant and cosmetic, skin external agent containing the same | |
| CN1252990A (en) | Vitamin A stable cleaning composition | |
| JPH07100357A (en) | Emulsified composition | |
| JP4052546B2 (en) | Skin preparation | |
| JPH0381400A (en) | Detergent composition | |
| JPS6093B2 (en) | Method for producing oil-based gel | |
| JPS6092399A (en) | Cream emulsion cleaning agent | |
| JP2003104826A (en) | W/o/w composite emulsion | |
| JP3596636B2 (en) | Detergent composition | |
| JP3213868B2 (en) | Pack cosmetics | |
| JPH0374313A (en) | Composition for external use | |
| JP2003104836A (en) | W/o/w type emulsion | |
| GB1575201A (en) | Method of lubricating or softening the skin | |
| JP4456778B2 (en) | Gel composition and external preparation for skin comprising the same | |
| JPS62195316A (en) | Dermatic drug | |
| JP3462332B2 (en) | Oil gelling agent and cosmetic containing the same |